Policies & RegulationsPharmacyHospitalsPharma & DistributionDrug ApprovalsIP IssuesDomestic NDD
  news bulletin  
Hospitals still want incentives in the meantime
by Eui Kyoung Yoon (ekyeun@dreamdrug.com)
Published : Feb 25, 2014 00:08:13
There will be conflicts in the pharmaceutical and healthcare industries until the market price system is rescinded in July, industry experts said Monday.

According to sources, big hospitals still ask quotes to pharmaceutical companies with an intention to purchase drugs at lower prices. It seems that they want to earn incentives for the next few months as long as the market price system is active.

Korean pharmaceutical companies are major victims. An sales representative of a Korean drugmaker said, “They asked price estimates to me and said they will switch current manufacturers to others if the prices are not low enough”

The management of a hospital and the doctors have different interests. The management wants to purchase cheaper drugs, but most doctors don’t like them. Although the hospital purchases a drug from a different manufacturer for incentives, they can’t get the incentives if the doctors don’t prescribe it.

Industry experts said that multinational drugmakers with brand-name drugs will have a conflict with pharmaceutical wholesalers as the drugmakers wouldn’t lower their prices while big hospitals pressure the wholesalers to cut the prices.
Reply 0
Name Password
Popular News
Champix to be covered, starting Feb 2015
First generic version of Omacor approved
OTC drugs will be available at some resorts
Novartis Korea and KPWA agreed on margin increase
MSD’s new COX-2 inhibitor Arcoxia approved
All materials contained on this site are protected by Korean copyright law and may not be reproduced, distributed, transmitted,
displayed, published or broadcast without the prior consent of dailypharm.com